Reuters-- Australian blood products and vaccines maker CSL said on Thursday U.S. competition regulators had yet to make a decision on its proposed $3.1 billion takeover of smaller rival Talecris Biotherapeutics Holdings Corp .
Reuters-- Australian blood products and vaccines maker CSL said on Thursday U.S. competition regulators had yet to make a decision on its proposed $3.1 billion takeover of smaller rival Talecris Biotherapeutics Holdings Corp .
